|4May 12, 5:51 PM ET

Hooper Suzanne Sawochka 4

4 · NGM BIOPHARMACEUTICALS INC · Filed May 12, 2023

Insider Transaction Report

Form 4
Period: 2023-05-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-10+78,40778,407 total
    Exercise: $3.69Exp: 2033-05-09Common Stock (78,407 underlying)
Footnotes (1)
  • [F1]The stock option shall vest in four (4) approximately equal quarterly installments, such that the option shall be fully vested on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day prior to the Issuer's next annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION